ifenprodil has been researched along with conantokin-t in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adams, AC; Keefe, KA; Layer, RT; McCabe, RT | 1 |
Dai, Q; Dong, M; Hu, J; Liu, Z; Mao, W; Prorok, M; Su, R; Yu, S; Yu, Z; Zhu, C | 1 |
2 other study(ies) available for ifenprodil and conantokin-t
Article | Year |
---|---|
Effects of conantokins on L-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression.
Topics: Animals; Antiparkinson Agents; Conotoxins; DNA-Binding Proteins; Drug Interactions; Early Growth Response Protein 1; Excitatory Amino Acid Antagonists; Gene Expression; Genes, fos; Genes, Immediate-Early; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Levodopa; Male; Mollusk Venoms; Peptides; Pipecolic Acids; Piperidines; Rats; Rats, Sprague-Dawley; Transcription Factors | 2000 |
A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.
Topics: Animals; Conotoxins; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Locomotion; Male; Mice; Morphine Dependence; Naloxone; Piperidines; Receptors, N-Methyl-D-Aspartate; Spatial Memory | 2021 |